Wonkyung Byon Selected Research

Body Weight (Weight, Body)

2/2024	Population pharmacokinetic modeling of oral brepocitinib in healthy volunteers and patients with immuno-inflammatory diseases.
1/2023	Evaluation of safety, pharmacokinetics, and pharmacodynamics of apixaban in pediatric subjects at risk of venous or arterial thrombotic disorder.
11/2022	Apixaban Use in Obese Patients: A Review of the Pharmacokinetic, Interventional, and Observational Study Data.
8/2021	Correction to: Efficacy, Safety, and Exposure of Apixaban in Patients with High Body Weight or Obesity and Venous Thromboembolism: Insights from AMPLIFY.
1/2021	Efficacy, Safety, and Exposure of Apixaban in Patients with High Body Weight or Obesity and Venous Thromboembolism: Insights from AMPLIFY.
1/2021	Population pharmacokinetics and exposure-response analyses of varenicline in adolescent smokers.
12/2013	Effect of extremes of body weight on the pharmacokinetics, pharmacodynamics, safety and tolerability of apixaban in healthy subjects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wonkyung Byon Research Topics

Disease

7	Body Weight (Weight, Body) 02/2024 - 12/2013
7	Atrial Fibrillation 11/2022 - 01/2013
6	Venous Thromboembolism 01/2023 - 01/2013
5	Stroke (Strokes) 01/2020 - 01/2013
3	Obesity 11/2022 - 01/2021
2	Venous Thrombosis (Deep-Vein Thrombosis) 01/2023 - 10/2019
2	Pulmonary Embolism 01/2023 - 10/2019
2	Hemorrhage 01/2021 - 01/2020
2	Nausea 01/2021 - 11/2013
1	Atopic Dermatitis (Atopic Eczema) 01/2022
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Vomiting 01/2021
1	Chronic Renal Insufficiency 01/2020
1	Brain Diseases (Brain Disorder) 10/2014
1	Embolism (Embolus) 12/2013
1	Headache (Headaches) 11/2013
1	Achlorhydria (Hypochlorhydria) 01/2013
1	Pain (Aches) 07/2010
1	Fibromyalgia (Fibrositis) 07/2010

Drug/Important Bio-Agent (IBA)

10	apixabanIBA 01/2023 - 01/2013
4	Factor Xa InhibitorsIBA 10/2019 - 01/2013
3	Factor Xa (Coagulation Factor Xa)IBA 01/2023 - 12/2013
2	antineoplaston A10 (A 10)IBA 02/2024 - 01/2020
2	Warfarin (Coumadin)FDA LinkGeneric 01/2021 - 01/2020
2	CreatinineIBA 01/2020 - 07/2010
1	AnticoagulantsIBA 01/2023
1	Organic Anion TransportersIBA 01/2022
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2022
1	Organic Cation Transporter 1IBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Janus Kinase 1IBA 01/2022
1	abrocitinibIBA 01/2022
1	Varenicline (Chantix)FDA Link 01/2021
1	Enoxaparin (Lovenox)FDA LinkGeneric 01/2021
1	kappa Opioid Receptors (kappa Opioid Receptor)IBA 10/2014
1	Proton Pump InhibitorsIBA 01/2013
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2013
1	AntacidsIBA 01/2013
1	Pregabalin (Lyrica)FDA Link 07/2010

Therapy/Procedure

1	Therapeutics 01/2023
1	Orthopedic Procedures 01/2013